Kerafast

The World’s Oldest Cancer, Found in Dogs

Around 6,000 years ago, a contagious canine cancer began in Asia and has since spread around the world between dogs, likely during mating. The cancer was able to travel overseas mainly due to maritime activities. Rising from one original dog and spreading to new dogs around the world, today, canine transmissible venereal tumor (CTVT) is 

Continue Reading…

Super-resolution reveals the basis of interchromosomal linkages

Super-resolution microscopy has allowed scientists at the Stowers Institute for Medical Research to identify what causes interchromosomal linkages. Their findings cited our c-Myc lentivirus and  were published in the Journal of Cell Biology. The composition of interchromosomal linkages Interchromosomal linkages were discovered by researchers in the 1960s while studying the organization of the human genome; 

Continue Reading…

Using Gold Nanoparticles for Vaccine Delivery

An international team of researchers has been able to demonstrate the impact of nanoparticles on human B lymphocytes, the immune cells responsible for antibody production. The results of their research, published in the journal ACS Nano, could lead to more effective vaccines and other therapeutics. Nanoparticles as Vaccine ‘Vehicles’ Because B lymphocytes are responsible for 

Continue Reading…

Using Nanobodies to Improve CAR T-Cell Therapy

Researchers at Boston Children’s Hospital and MIT have recently been able to show that mini-antibodies called nanobodies – previously discovered more than 20 years ago – may be able to resolve an issue in the cancer field: making chimeric antigen receptor (CAR) T-cell therapies functional in solid tumors. Their research was published in the journal 

Continue Reading…

A Future Focus for Parkinson’s Treatment

In a study published by the Journal of Biological Chemistry, scientists at UPenn School of Veterinary Medicine discovered that the enzyme cytochrome P450 2D6 (CYP2D6) plays a role in triggering Parkinson’s disease and represents a new focus for Parkinson’s treatment. Chemically induced Parkinson’s A few decades ago, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) was found to induce the onset 

Continue Reading…

A New Target for Anti-Inflammation Therapeutics

Researchers from Washington State University recently discovered a critical step in the body’s inflammatory response that may aid in the development of anti-inflammatory treatments. Their findings, which were published in the journal Nature Communications, cited an integrin beta 3 antibody developed by researchers at the Blood Center of Wisconsin and now available via the Kerafast 

Continue Reading…